EDGAR Filing Documents for 0000947871-18-000671

Form SC 13D - General statement of acquisition of beneficial ownership:

SEC Accession No. 0000947871-18-000671

Filing Date

2018-08-15

Accepted

2018-08-15 17:29:51

Documents

Group Members

ORBIMED CAPITAL GP VI LLC

Document Format Files

Seq	Description	Document	Type	Size
1	REPORT BENEFICIAL OWNERSHIP	ss103736_sc13d.htm	SC 13D	99464
2	JOINT FILING AGREEMENT	ss103736_ex9901.htm	EX-99.1	13107
	Complete submission text file	0000947871-18-000671.txt		114078

Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022

Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400

ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address CANNON PLACE 78 CANNON STREET LONDON X0 EC4N 6AF

Business Address CANNON PLACE 78 CANNON STREET LONDON X0 EC4N 6AF 484-321-2700

Realm Therapeutics plc (Subject) CIK: 0001718903 (see all company filings)

IRS No.: 133933588 | State of Incorp.: X0
Type: SC 13D | Act: 34 | File No.: 005-90569 | Film No.: 181021835
SIC: 2834 Pharmaceutical Preparations